A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis (Q57904446)
Jump to navigation
Jump to search
article by Efstathios Kastritis et al published 18 April 2012 in Blood
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis |
article by Efstathios Kastritis et al published 18 April 2012 in Blood |
Statements
A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis (English)
0 references
18 April 2012
0 references
119
0 references
5384-5390
0 references
23
0 references